Skip to content

Open study of ORM

Open study of ORM - Open study of ORM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029199
Enrollment
10
Registered
2017-09-20
Start date
2017-09-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periodontal disease

Interventions

administer ORM twice daily for 4weeks

Sponsors

ROHTO pharmaceutical CO.,LTD
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Patients aged 20 to 64 years on the day of signing the informed consent -Mild to moderate periodontal disease patients

Exclusion criteria

Exclusion criteria: -Patients who have systemic diseases thought to affect evaluation of this study -Patients who have serious oral diease thought to affect evaluation of this study -Patients who smoke

Design outcomes

Primary

MeasureTime frame
Measurement of periodontal disease index at week4 .Taking photography of oral cavity at week4.

Countries

Japan

Contacts

Public ContactMasahiko Kawai

ROHTO pharmaceutical CO.,LTD Clinical development group Development & Planning office

kawaim@rohto.co.jp0774-71-8820

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026